Nanoconjugate Platforms Development Based in Poly(<svg     style="vertical-align:-4.698pt;width:13.15px;" id="M1" height="21.9375" version="1.1" viewBox="0 0 13.15 21.9375" width="13.15"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,-0,0,-.022,.062,16.025)"><path id="x1D6FD" d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5
t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" /></g>

		
	
</svg>,L-Malic Acid)
Methyl Esters for Tumor Drug Delivery

<table>Elution profiles obtained by sec-HPLC for <i>co</i>PMLA-M<svg height="14.5375" id="M89" style="vertical-align:-3.25793pt" version="1.1" viewbox="0 0 41.474998 14.5375" width="41.474998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,14.5375)">
<g transform="translate(72,-60.37)">
<text transform="matrix(1,0,0,-1,-71.95,63.67)">
<tspan style="font-size: 12.50px; " x="0" y="0">e</tspan>
</text>
<text transform="matrix(1,0,0,-1,-66.4,60.55)">
<tspan style="font-size: 8.75px; " x="0" y="0">5</tspan>
<tspan style="font-size: 8.75px; " x="4.3759999" y="0">0</tspan>
</text>
<text transform="matrix(1,0,0,-1,-57.15,63.67)">
<tspan style="font-size: 12.50px; " x="0" y="0">H</tspan>
</text>
<text transform="matrix(1,0,0,-1,-48.12,60.55)">
<tspan style="font-size: 8.75px; " x="0" y="0">5</tspan>
<tspan style="font-size: 8.75px; " x="4.3759999" y="0">0</tspan>
</text>
</g>
</g>
</svg> at time zero (a) and after 24 hours of incubation (b) in  human plasma at <svg height="11.0375" id="M90" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 20.200001 11.0375" width="20.200001" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0375)">
<g transform="translate(72,-63.17)">
<text transform="matrix(1,0,0,-1,-71.95,63.39)">
<tspan style="font-size: 12.50px; " x="0" y="0">3</tspan>
<tspan style="font-size: 12.50px; " x="6.2515001" y="0">7</tspan>
</text>
<text transform="matrix(1,0,0,-1,-59.45,68.56)">
<tspan style="font-size: 8.75px; " x="0" y="0">∘</tspan>
</text>
</g>
</g>
</svg>C. Samples were extracted with chloroform/ethylacetate before chromatography (see Section <a href="https://static.hindawi.com/articles/jnm/volume-2010/825363/figures/#sec2">2</a>).</table>

Journal of Nanomaterials

fig3

Figure 3

Figure 3: Nanoconjugate Platforms Development Based in Poly(<svg     style="vertical-align:-4.698pt;width:13.15px;" id="M1" height="21.9375" version="1.1" viewBox="0 0 13.15 21.9375" width="13.15"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,-0,0,-.022,.062,16.025)"><path id="x1D6FD" d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5
t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" /></g>

		
	
</svg>,L-Malic Acid)
Methyl Esters for Tumor Drug Delivery 

Journal of Nanomaterials

Nanoconjugate Platforms Development Based in Poly( ,L-Malic Acid) Methyl Esters for Tumor Drug Delivery

Figure 3

Nanoconjugate Platforms Development Based in Poly(,L-Malic Acid) Methyl Esters for Tumor Drug Delivery